Welcome to our dedicated page for Camden Natl SEC filings (Ticker: CAC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Camden National Corporation (NASDAQ: CAC), a Maine‑incorporated bank holding company. Through these filings, investors can review the company’s official disclosures about its commercial banking and wealth management activities, financial performance, capital position, and corporate governance.
Camden National Corporation files a range of documents with the SEC, including Form 8‑K current reports that announce material events. Recent 8‑K filings referenced in the available information cover topics such as quarterly earnings releases, dividend declarations, investor presentations, and board succession changes. These filings often include or reference press releases that detail net income, loan and deposit levels, asset quality metrics, and capital ratios, as well as information about quarterly cash dividends on the company’s common stock.
In addition to current reports, investors can use this filings page to locate the company’s annual reports on Form 10‑K and quarterly reports on Form 10‑Q, which provide more extensive discussions of Camden National Corporation’s business model, risk factors, regulatory environment, and financial statements. For a bank holding company, these periodic reports are key sources for understanding loan portfolios, deposit funding, capital adequacy, and non‑interest income streams, alongside the risk and capital disclosures that accompany them.
Users can also review filings related to dividend actions and board changes, as reflected in 8‑K items on dividend declarations and director retirement and succession. Where applicable, insider transaction reports on Form 4 can be consulted to see equity transactions by directors and officers.
Stock Titan’s platform enhances these regulatory documents with AI‑powered summaries that highlight the main points of lengthy filings, helping readers quickly identify key financial and governance information. Real‑time updates from the SEC’s EDGAR system, combined with simplified explanations of complex forms such as 10‑K, 10‑Q, 8‑K, and Form 4, make it easier to follow Camden National Corporation’s regulatory reporting and its implications for the CAC stock.
Camden National Corporation is asking shareholders to vote at its 2026 virtual annual meeting on May 19, 2026, at 9:00 a.m. Eastern. The proxy covers electing eleven directors for one-year terms, an advisory “Say‑on‑Pay” vote on named executive officer compensation, and ratifying RSM US LLP as independent auditor for 2026.
Shareholders of record on March 25, 2026, with 16,976,156 common shares outstanding, may vote by mail, phone, internet, or during the live webcast. The statement also details board composition and independence, committee responsibilities, director pay and stock ownership guidelines, and the company’s corporate responsibility and risk oversight framework, including cybersecurity and enterprise risk management.
Camden National Corporation declared a quarterly cash dividend of $0.42 per share for its common stock. The dividend is payable on April 30, 2026 to shareholders of record as of April 15, 2026.
The company notes this payout represents an annualized dividend yield of 3.57%, based on a March 30, 2026 closing share price of $47.03. Camden National is described as Northern New England's largest publicly traded bank holding company, with $7.0 billion in assets and 72 banking centers in Maine and New Hampshire.
Camden National Corp CEO Simon Griffiths received an equity grant of 4,610 restricted stock units under the company’s 2023-2025 Long-Term Performance Share Plan. These units are scheduled to vest on April 25, 2026, contingent on continued employment through that date.
Each restricted stock unit converts into one share of common stock at vesting. After this grant, Griffiths holds 39,376 shares in total, including 30,634 restricted stock units and restricted shares that remain subject to vesting and forfeiture conditions.
Camden National Corp EVP Andrew Forbes received an equity award of 507 restricted stock units (RSUs) that will convert into the same number of common shares when they vest. The award was granted at no cash cost and is scheduled to vest on April 25, 2026, subject to continued employment.
After this grant, Forbes holds a total of 5,401 shares of Camden National common stock directly, including 4,761 RSUs and restricted shares that remain subject to vesting and forfeiture conditions. This filing reflects routine compensation rather than an open‑market stock purchase or sale.
Camden National Corp executive vice president Garrett McKnight received an equity award of 545 restricted stock units of common stock. The grant was made at no cash cost and is scheduled to vest on April 25, 2026, subject to continued employment through that date.
Each restricted stock unit converts into one share of common stock at vesting. After this award, McKnight directly holds 5,626 shares, including 4,947 restricted stock units and restricted shares that remain subject to vesting and forfeiture conditions.
Martel William H reported acquisition or exercise transactions in this Form 4 filing.
Camden National Corp EVP William H. Martel received a grant of 1,064 shares of common stock as restricted stock units under the company’s 2023-2025 Long-Term Performance Share Plan. The award carries no purchase price and is scheduled to vest on April 25, 2026, contingent on continued employment. After this grant, Martel directly holds 21,355 shares of common stock, including 8,588 restricted stock units and restricted shares that remain subject to vesting and forfeiture conditions. This filing reflects equity-based compensation rather than an open-market share purchase or sale.
Camden National Corp EVP Barbara Raths received a stock-based compensation award. She acquired 551 restricted stock units under the company’s 2023-2025 Long-Term Performance Share Plan, at no cash price. The units are scheduled to vest on April 25, 2026, subject to continued employment.
Each restricted stock unit converts into one share of common stock at vesting. After this grant, she beneficially owns 8,496 shares of Camden National common stock, including 5,828 restricted stock units and restricted shares that remain subject to vesting and forfeiture conditions.
Smith Ryan A reported acquisition or exercise transactions in this Form 4 filing.
Camden National Corp EVP Ryan A. Smith received a grant of 1,015 restricted stock units of common stock at no cash cost. The units were awarded under the issuer's 2023-2025 Long-Term Performance Share Plan and are scheduled to vest on April 25, 2026, subject to continued employment.
Each restricted stock unit represents the right to receive one share of common stock upon vesting. After this award, Smith directly holds 23,413 shares of common stock, including 7,852 restricted stock units and restricted shares that remain subject to vesting and forfeiture restrictions.
Archer Michael R reported acquisition or exercise transactions in this Form 4 filing.
Camden National Corp EVP Michael R. Archer received a grant of 967 shares of common stock in the form of restricted stock units as compensation. These units were awarded at no cash cost and are scheduled to vest on April 25, 2026, if he remains employed through that date.
After this grant, Archer holds a total of 19,815.073 shares of common stock directly, including 9,157 restricted stock units and restricted shares that are still subject to vesting and forfeiture conditions.
Smyth Renee reported acquisition or exercise transactions in this Form 4 filing.
Camden National Corp executive vice president Renee Smyth received a grant of 896 restricted stock units as equity compensation. These units were awarded at no cash cost and are scheduled to vest on April 25, 2026, contingent on continued employment. Following this grant, Smyth directly holds 28,733.604 shares of common stock, including 6,925 restricted stock units and restricted shares that remain subject to vesting and forfeiture conditions.